Testing fluid removal through the belly in heart-kidney failure
Part of Heart & circulation clinical trials.
This trial studies a treatment that removes extra fluid through a catheter placed in the abdomen (peritoneal ultrafiltration) for people with “cardio-renal syndrome” (heart and kidney problems together). It may help those who stay congested despite high-dose water pills (diuretics) and have certain heart circulation and fluid signs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your heart pumping strength is reduced (left side ejection fraction 60% or less)
- You have serious ongoing shortness of breath/fatigue from heart failure (NYHA class III–IV) despite standard medicines
- You have signs of right-sided heart strain and fluid overload, confirmed by a heart pressure test (right heart catheterization) after stable meds
- Your kidneys are not in end-stage failure (measured kidney filtration needs to be above a cutoff)
- You have needed high-dose IV diuretics for congestion at least once in the last 6 months, showing the usual water pills may not be working
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using belly pressure and bedside ultrasound can help doctors better manage fluid removal (decongestion) in people hospitalized with heart failure. The goal is to see if this approach leads to better outcomes.
This trial tests a device designed to safely remove extra fluid from patients hospitalized with worsening heart failure. It may help those who are not responding well to standard water pills (diuretics).
This trial tests a wearable device that removes extra fluid from your body without using the kidneys. It may help people with heart failure who still have fluid buildup despite taking high doses of water pills.
This trial is for people hospitalized with heart failure and signs of fluid overload, such as swelling or fluid in the lungs. It aims to check if patients still have extra fluid when they go home, which may help improve their recovery.
This trial tests a treatment to help remove extra fluid from the body when the heart is too weak to pump effectively. It may help people in intensive care who have fluid buildup and are at risk of kidney problems.
This study tests whether using ultrasound-guided treatment to reduce fluid buildup in the body can help people hospitalized for worsening heart failure feel better faster. It's for adults admitted with heart failure and high BNP levels.
Hear when a new Congestive Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.